Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      16 trials found for "Breast cancer", "Breast Neoplasm"

      All(16)
      Recruiting()
      Not yet recruiting()
      Recruiting
      NCT04654208
      Swedish Ibrance Registries Insights (SIRI)

      Malignant Neoplasm of Breast

      Male or Female
      18 - 99 years
      1study location(s)
      Recruiting
      NCT04937660
      Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC

      Metastatic Breast Cancer

      Male or Female
      18 - 90 years
      12study location(s)
      May 01, 2025 - Planned start date (Not yet recruiting)
      NCT06962969
      A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database

      Advanced or Metastatic Breast Cancer

      Females
      18+ years
      Apr 30, 2025 - Planned start date (Not yet recruiting)
      NCT06961331
      Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-postive Metastatic Breast Cancer.

      Metastatic HER2+ Advanced Breast Cancer

      Male or Female
      18+ years
      Apr 30, 2025 - Planned start date (Not yet recruiting)
      NCT06735742
      A Study to Learn About the Safety of TALZENNA for the Treatment of Breast Cancer

      Pediatric Breast cancer

      Male or Female
      0+ years
      Mar 31, 2025 - Planned start date (Not yet recruiting)
      NCT06873191
      A Study to Learn More About Tukysa Once it is Out in the Korean Market

      HER2-positive Locally Advanced Unresectable, Metastatic Breast Cancer

      Male or Female
      18+ years

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(16)
      Recruiting()
      Not yet recruiting()

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.